Stock Scorecard



Stock Summary for Hyperfine Inc - Class A (HYPR) - $1.11 as of 2/16/2026 2:16:50 PM EST

Total Score

12 out of 30

Safety Score

21 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for HYPR

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for HYPR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for HYPR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for HYPR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for HYPR (21 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for HYPR

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities 1/27/2026 7:59:00 PM
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years 1/23/2026 8:58:00 AM
Portable MRI study tests contrast agents to sharpen better brain scans 1/19/2026 7:58:00 PM
HYPR Stock Price, News & Analysis 1/17/2026 11:27:00 AM
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic 1/16/2026 10:28:00 PM
Revenues Tell The Story For Hyperfine, Inc. (NASDAQ:HYPR) As Its Stock Soars 34% 1/15/2026 10:28:00 PM
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent 1/1/2026 10:57:00 PM
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent 12/30/2025 11:27:00 AM
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent 12/30/2025 11:09:00 AM
Hyperfine Signs Amended ATM Sales Agreement With B. Riley Securities and BTIG 12/30/2025 10:09:00 AM

Financial Details for HYPR

Company Overview

Ticker HYPR
Company Name Hyperfine Inc - Class A
Country USA
Description Hyperfine Inc. is a trailblazer in medical technology, dedicated to revolutionizing access to MRI through its cutting-edge point-of-care imaging solutions. As the creator of the world’s first FDA-cleared portable MRI system, the company enhances patient care by providing high-quality imaging directly at the bedside, thereby streamlining clinical decision-making processes. By prioritizing cost reduction and patient convenience, Hyperfine positions itself strategically in a rapidly evolving healthcare landscape, unlocking significant market opportunities as demand for innovative diagnostic imaging solutions escalates. Its unique offerings are set to play a transformative role in advancing healthcare delivery across diverse medical settings.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date 3/16/2026

Stock Price History

Last Day Price 1.11
Price 4 Years Ago 0.84
Last Day Price Updated 2/16/2026 2:16:50 PM EST
Last Day Volume 359,937
Average Daily Volume 469,813
52-Week High 2.22
52-Week Low 0.53
Last Price to 52 Week Low 109.43%

Valuation Measures

Trailing PE N/A
Industry PE 43.14
Sector PE 68.60
5-Year Average PE -4.50
Free Cash Flow Ratio 4.27
Industry Free Cash Flow Ratio 33.91
Sector Free Cash Flow Ratio 27.98
Current Ratio Most Recent Quarter 3.63
Total Cash Per Share 0.26
Book Value Per Share Most Recent Quarter 0.33
Price to Book Ratio 4.03
Industry Price to Book Ratio 2.75
Sector Price to Book Ratio 37.88
Price to Sales Ratio Twelve Trailing Months 10.18
Industry Price to Sales Ratio Twelve Trailing Months 3.23
Sector Price to Sales Ratio Twelve Trailing Months 24.89
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 82,113,000
Market Capitalization 91,145,430
Institutional Ownership 12.51%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 7.95%
Reported EPS 12 Trailing Months -0.52
Reported EPS Past Year -0.38
Reported EPS Prior Year -0.56
Net Income Twelve Trailing Months -40,052,000
Net Income Past Year -40,720,000
Net Income Prior Year -44,238,000
Quarterly Revenue Growth YOY -5.70%
5-Year Revenue Growth 105.01%
Operating Margin Twelve Trailing Months -259.50%

Balance Sheet

Total Cash Most Recent Quarter 21,564,000
Total Cash Past Year 37,645,000
Total Cash Prior Year 75,183,000
Net Cash Position Most Recent Quarter 21,386,000
Net Cash Position Past Year 37,467,000
Long Term Debt Past Year 178,000
Long Term Debt Prior Year 178,000
Total Debt Most Recent Quarter 178,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 49,040,000
Total Stockholder Equity Prior Year 84,399,000
Total Stockholder Equity Most Recent Quarter 26,872,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -32,228,000
Free Cash Flow Per Share Twelve Trailing Months -0.39
Free Cash Flow Past Year -39,150,000
Free Cash Flow Prior Year -42,613,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.02
20-Day Bollinger Lower Band 0.80
20-Day Bollinger Middle Band 1.16
20-Day Bollinger Upper Band 1.52
Beta 1.09
RSI 47.47
50-Day SMA 1.03
150-Day SMA 1.22
200-Day SMA 0.00

System

Modified 2/17/2026 12:57:11 AM EST